Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Sarda ProteinsBOM:519242 64 Market Cap is ₹168.8 Mil as of Aug. 05, 2026. GuruFocus rates BOM:519242 with a GF Score™ of 64/100 and a GF Value™ of ₹115.47 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 2,046 Consumer Packaged Goods companies, Sarda Proteins ranks worse than 96.43% on this metric.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Sarda Proteins's share price for the quarter that ended in Jun. 2026 was ₹93.13. Sarda Proteins's Shares Outstanding (EOP) for the quarter that ended in Jun. 2026 was 1.7 Mil. Therefore, Sarda Proteins's market cap for the quarter that ended in Jun. 2026 was ₹160.7 Mil.
Sarda Proteins's quarterly market cap
declined
from Sep. 2025 (₹203.0 Mil) to Dec. 2025 (₹127.9 Mil) but then
increased
from Dec. 2025 (₹127.9 Mil) to Jun. 2026 (₹160.7 Mil).
Sarda Proteins's annual market cap
declined
from Mar. 2023 (₹99.7 Mil) to Mar. 2024 (₹92.8 Mil) but then
increased
from Mar. 2024 (₹92.8 Mil) to Mar. 2025 (₹215.3 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Sarda Proteins's Enterprise Value for Today is ₹169.0 Mil.
Sarda Proteins (BOM:519242) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Sarda Proteins Market Cap Related Terms
Sarda Proteins Market Cap Historical Data
* Premium members only.
The historical data trend for Sarda Proteins's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Packaged Foods subindustry, Sarda Proteins's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sarda Proteins Market Cap vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Sarda Proteins's Market Cap distribution charts can be found below:
* The bar in red indicates where Sarda Proteins's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Sarda Proteins's Market Cap for the fiscal year that ended in Mar. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sarda Proteins (BOM:519242) has a Market Cap of ₹168.8 Mil as of Aug. 05, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Sarda Proteins and its competitors. According to the industry distribution chart, Sarda Proteins ranks #1973 out of 2046 companies in the Consumer Packaged Goods industry, placing it in the top 96.4%.
Is Sarda Proteins' Market Cap too high?
Sarda Proteins' current Market Cap is ₹168.8 Mil. Based on the distribution chart, Sarda Proteins ranks #1973 out of 2046 companies in the Consumer Packaged Goods industry, which is in the bottom quartile relative to peers. Overall, Sarda Proteins has a GF Score™ of 64/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Sarda Proteins' Market Cap compare to KHC and GIS?
According to the Consumer Packaged Goods industry distribution chart, Sarda Proteins ranks #1973 out of 2046 companies for Market Cap. This places Sarda Proteins in the lower half of its industry. The industry median Market Cap is 105.73. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Consumer Packaged Goods company?
The median Market Cap among Consumer Packaged Goods companies is 105.73, based on 2,046 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Sarda Proteins and its competitors. For the Consumer Packaged Goods industry, the median Market Cap is 105.73 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sarda Proteins's current Market Cap is ₹168.8 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sarda Proteins stock overvalued right now?
Based on GuruFocus' analysis, Sarda Proteins (BOM:519242) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹115.47, compared to a current price of ₹97.78 — trading 15.3% below its estimated fair value. The current Market Cap is ₹168.8 Mil. Sarda Proteins' overall GF Score™ is 64/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Sarda Proteins (BOM:519242), the current Market Cap is ₹168.8 Mil as of Aug. 05, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sarda Proteins (BOM:519242) Overvalued in 2026?
Based on GuruFocus' analysis, Sarda Proteins stock appears to be undervalued.
The current stock price of ₹97.78 is trading 15.3% below its estimated GF Value™ of ₹115.47.
GuruFocus considers Sarda Proteins to be Modestly Undervalued.
Key valuation signals for BOM:519242:
Market Cap: ₹168.8 Mil
GF Value™: ₹115.47 vs. price of ₹97.78 (15.3% below fair value)
No single metric tells the full story. See the BOM:519242 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Sarda Proteins Ltd is a dynamic company driving innovation in renewable energy, with core expertise in solar plant services, carbon-credit markets, intelligent asset management, and automation technologies. The company mainly deals in the trading of solar cells. It has only one segment, i.e., Renewable Energy Sector Solar Cell Products.
64GF Score
Get the complete analysis for BOM:519242
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:519242 has been successfully added to your 
